Skip to content

Clinical trials

Phase 2/3 Obesity trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Phase 2/3 Status: Unknown status Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20142
20163
20171
20192
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
E-DA Hospital1
Federico II University1
Glaser Pediatric Research Network1
Hanyang University1
Hillel Yaffe Medical Center1
Hospital General de México Dr. Eduardo Liceaga1
Prof. Tony hayek MD1
ReShape Lifesciences1
Tan Tock Seng Hospital1
University Health Network, Toronto1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity12
Dyslipidemias2
Weight Loss2
Atherosclerosis1
Chronic Pain1
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Hypertension1
Insulin Resistance1
Metabolic Syndrome1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.